CACLP - The largest IVD Expo & Conference

Agilent Technologies successfully delivered the first batch of targeted capture products produced in China

Industry news | 09 September, 2021 | CACLP

On September 9, 2021, Agilent successfully delivered the first batch of SureSelect targeted capture probe products produced in China at its Hangzhou production base. This completed production delivery marks the completion of China production line recently, which has achieved the production level and quality assurance consistent with Agilent's global standards. In the future, China production line will produce and supply high-quality SureSelect targeted capture products to more quickly respond to the needs of second-generation sequencing customers for targeted capture products.


SureSelect Targeted Capture Probe Kit. Credit: Agilent Technologies



Kevin Meldrum, vice president and general manager of the Genomics Group of Agilent Technologies, said: “With the rapid development of precision medicine in China and the advancement of second-generation sequencing technology, China has become one of Agilent’s most important strategic markets in the world. This time the presence of  SureSelect targeted capture product production line that has been built and put into production in China will allow us to respond to the needs of domestic customers more quickly and timely in the future, fulfilling our commitment of rooting in China and continuously  providing Chinese users with the best quality services. Carrying out and expanding production in China It is also Agilent’s response to the policy call of Made in China 2025 to further promote the continuous development of domestic precision medicine and technological innovation.”


Zheng Xiaowei, General Manager of Diagnostics and Genomics Division of Agilent Technologies China said: "In 2020, with the support of the headquarters Agilent China Diagnostics and Genomics Group (DGG) has completed the 5-year development strategic plan for domestic business-DGG China 2025. The domestic production targeted capture products delivered today are a true embodiment of the implementation of DGG China 2025 strategy. The successful use of this production line will provide users engaged in tumor sequencing, molecular genetic testing, pathogenic microorganism testing and life science research with a faster product delivery cycle, and further improving customer service capabilities and customer satisfaction".




The first completed production delivery of SureSelect targeted capture products in China



Wang Xiaobo, General Manager of Agilent Bioscience Co. Ltd (Hangzhou) and Product Production Director of Agilent Technologies Genomics Bruce Jerpseth, jointly stated that in the construction and operation of China production line of SureSelect targeted capture products, Agilent China worked closely with the global team to overcome challenges brought by the global epidemic. With the collective efforts of domestic and foreign members of the project team, the planning, construction, debugging, quality inspection and production of the production line have been completed to ensure that the products delivered by China production line are consistent with the global quality standards .


Agilent Bioscience Co. Ltd (Hangzhou) where the new SureSelect targeted capture product production line is located, is the R&D, manufacturing and operation center of Agilent's global flow cytometry system and real-time cell analysis system. With the addition of the SureSelect product line, Agilent Bioscience Co. Ltd (Hangzhou)'s manufacturing capabilities have been further expanded. Its manufactured products will be widely used in drug development, immunotherapy, tumor marker detection and development, genetic testing, vaccine development, toxicology, safety pharmacology, quality control and basic life science research.



Agilent Bioscience Co. Ltd (Hangzhou)




Filed under:
Press contact CACLP - The largest IVD Expo & Conference

Stay in touch with CACLP News

We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News, sign-up for our newsletter today.

  • Name *
  • Email *
  • Company name *
  • Country *
    CACLP - The largest IVD Expo & Conference

By subscribing our newsletter, you agree to our Privacy Policy. You can unsubscribe at anytime.

Share
Opening Countdown
0 0 0

Day(s)

0 0

Hour(s)

0 0

Min(s)

Room 2201-2203 & 2205, Cloud Nine Plaza
1118 West Yan’an Road
Shanghai, China
200052

Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )

We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy & Cookies for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

CACLP - The largest IVD Expo & Conference